Eco Science Solutions Inc (ESSI) reported QQ2 2026 results with no revenue disclosed in the provided data, accompanied by an operating expenditure build that produced a net loss of $262,843 and an earnings per share of -$0.005. R&D expense totaled $80,053, with operating expenses of $242,898 and other expenses of $162,845, contributing to the bottom-line shortfall. Net income declined appears to be driven by a burn-focused cost structure rather than top-line growth, as revenue figures were not disclosed in the quarter.
From a liquidity and balance-sheet perspective, ESSI exhibits meaningful stress. Cash on hand was $3,098 at quarter-end, while short-term debt stood at $7,075,663 and total current liabilities were $17,203,119. Total assets reported were $104,583, with total stockholders’ equity of -$17,098,536, indicating negative book value and a high reliance on external financing to fund operations. Operating cash flow was negative at -$91,889, with financing activities contributing $93,288 and resulting in a modest net cash increase of $1,399 for the period. Net debt stood at approximately $7.07 million, underscoring a fragile liquidity position for ESSI unless revenue generation or additional financing materializes.
Given the absence of disclosed revenue and the balance-sheet fragility, ESSI remains a high-risk, high-uncertainty investment. The near-term trajectory will hinge on monetization of the Herbo platform and any forthcoming licensing or enterprise deals, along with the company’s ability to manage burn and secure sustainable capital. Investors should closely monitor topline progress, cost discipline, and any management guidance on revenue milestones, financing plans, and liquidity runway.